Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 8
2003 5
2004 6
2005 7
2006 8
2007 7
2008 14
2009 10
2010 9
2011 9
2012 15
2013 11
2014 10
2015 9
2016 14
2017 18
2018 15
2019 23
2020 27
2021 17
2022 22
2023 13
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

236 results

Results by year

Filters applied: . Clear all
Page 1
Progression of the FIB-4 index among patients with chronic HCV infection and early liver disease.
Krassenburg LAP, Maan R, Puenpatom A, Erler NS, Welsch C, van Hees S, Cerrhoci O, Vermehren J, de Knegt RJ, Hansen BE, Zeuzem S, Vanwolleghem T, Janssen HLA, de Man RA, Feld JJ, van der Meer AJ. Krassenburg LAP, et al. Among authors: de man ra. BMJ Open Gastroenterol. 2023 Dec 7;10(1):e001209. doi: 10.1136/bmjgast-2023-001209. BMJ Open Gastroenterol. 2023. PMID: 38637963 Free PMC article.
Sustained response and HBsAg loss after nucleo(s)tide analogue discontinuation in chronic hepatitis B patients: the prospective SNAP study.
Brakenhoff SM, Claassen M, Honkoop P, de Knegt RJ, van der Eijk AA, Boonstra A, de Man RA, Sonneveld MJ. Brakenhoff SM, et al. Among authors: de man ra. Clin Res Hepatol Gastroenterol. 2024 Feb;48(2):102257. doi: 10.1016/j.clinre.2023.102257. Epub 2023 Dec 6. Clin Res Hepatol Gastroenterol. 2024. PMID: 38065523 Free article.
Induction of broad multifunctional CD8+ and CD4+ T cells by hepatitis B virus antigen-based synthetic long peptides ex vivo.
Jansen DTSL, de Beijer MTA, Luijten RJ, Kwappenberg K, Wiekmeijer AS, Kessler AL, Pieterman RFA, Bouzid R, Krebber WJ, de Man RA, Melief CJM, Buschow SI. Jansen DTSL, et al. Among authors: de man ra. Front Immunol. 2023 Sep 13;14:1163118. doi: 10.3389/fimmu.2023.1163118. eCollection 2023. Front Immunol. 2023. PMID: 37781393 Free PMC article.
Validation and optimization of AFP-based biomarker panels for early HCC detection in Latin America and Europe.
Beudeker BJB, Fu S, Balderramo D, Mattos AZ, Carrera E, Diaz J, Prieto J, Banales J, Vogel A, Arrese M, Oliveira J, Groothuismink ZMA, van Oord G, Hansen BE, de Man RA, Debes JD, Boonstra A. Beudeker BJB, et al. Among authors: de man ra. Hepatol Commun. 2023 Sep 15;7(10):e0264. doi: 10.1097/HC9.0000000000000264. eCollection 2023 Oct 1. Hepatol Commun. 2023. PMID: 37708457 Free PMC article.
Study protocol for a multicentre nationwide prospective cohort study to investigate the natural course and clinical outcome in benign liver tumours and cysts in the Netherlands: the BELIVER study.
Furumaya A, Haring MPD, van Rosmalen BV, Klompenhouwer AJ, Besselink MG, de Man RA, IJzermans JNM, Thomeer MGJ, Kramer M, Coolsen MME, Tushuizen ME, Schaapherder AF, de Haas RJ, Duiker EW, Kazemier G, van Delden OM, Verheij J, Takkenberg RB, Cuperus FJC, De Meijer VE, Erdmann JI; Dutch Benign Liver Tumor Group (DBLTG). Furumaya A, et al. Among authors: de man ra. BMJ Open. 2022 Sep 8;12(9):e055104. doi: 10.1136/bmjopen-2021-055104. BMJ Open. 2022. PMID: 36691222 Free PMC article.
236 results